Altimmune Announces Submission of Investigational New Drug Application for AdCOVID(TM) a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December

Stock Information for Altimmune Inc.

Loading

Please wait while we load your information from QuoteMedia.